Therefore, we compared the types of NAGS, CPS1, and citrin sequence variants found in all tumor samples with sequence variants found in individuals without known rare diseases, and patients with NAGS, CPS1, or citrin deficiencies to increase the power of comparison. This evidence concerns the gene SLC25A13 and neoplasm.